Skip to main content

Advertisement

SpringerLink
Log in

Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer

  • Gynecologic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

To assess the clinical efficacy and prognostic outcome of neoadjuvant chemotherapy (NACT) plus radical surgery (RS) as front line treatment in patients with FIGO stage III cervical cancer (CC).

Methods

In this retrospective study, 52 FIGO stage III CC patients treated from 2005 to 2015 were included. All patients received platinum-based chemotherapy. Patients reporting clinical response or stable disease after NACT underwent to RS and bilateral systematic pelvic lymphadenectomy with or without aortic lymphadenectomy or anterior exenteration. Patients with progressive disease underwent palliative management.

Results

After NACT, clinical response was observed in 23 patients (44 %): 4 (7.7 %) complete and 19 (36.5 %) partial responses, respectively. Also, 15 patients (28.8 %) had stable disease and 14 (26.9 %) showed disease progression. RS was performed in 40 cases (76.9 %): respectively, 28 (70 %) and 7 (17.5 %) underwent type C2 and D radical hysterectomy, while 5 patients (12.5 %) underwent anterior exenteration. At pathological evaluation, 23 patients (57.5 %) had positive pelvic nodes and 4 (10 %) also had positive aortic nodes. In 6 patients (15 %), moderate-severe (G3–G5) complications occurred. A total of 27 patients (67.5 %) received adjuvant therapy: 16 patients (40 %) received chemotherapy, 10 (25 %) received chemoradiation and 1 (2.5 %) received radiotherapy. Disease relapse occurred in 24 cases (60 %). After follow-up period of 60 months, the median OS of the whole population included was 37 months. Among the 40 surgically treated patients, median OS and DFS were 48 and 23 months, respectively.

Conclusions

NACT plus RS represent a valid alternative with acceptable morbidity for patients with stage III CC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50.

    Article  PubMed  Google Scholar 

  3. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev. 2005;14:677–86.

    Article  PubMed  Google Scholar 

  4. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999:340:1137–43.

    Article  CAS  PubMed  Google Scholar 

  5. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53.

    Article  CAS  PubMed  Google Scholar 

  6. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17:1339–48.

    CAS  PubMed  Google Scholar 

  7. Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13.

    CAS  PubMed  Google Scholar 

  8. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–61.

    Article  CAS  PubMed  Google Scholar 

  9. Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26:5802–12.

    Article  PubMed Central  Google Scholar 

  10. Neoadjuvant, Chemotherapy for Cervical Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy for locally advanced cervical cancer a systematic review and meta-analysis of individual patient data from 21 randomized trials. Eur J Cancer. 2003;39:2470–86.

    Article  Google Scholar 

  11. National Cancer Institute, National Institutes of Health, US Department of Health, US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 2009; Revised version 4.03 June 14, 2010.

  12. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–47.

    Article  CAS  PubMed  Google Scholar 

  13. Querleu D, Morrow CP. Classification of radical hysterectomy. Gynecol Oncol. 2009;115:314–5.

    Article  PubMed  Google Scholar 

  14. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009;250:177–86.

    Article  PubMed  Google Scholar 

  15. Rose P, Ali S, Whitney C, Lanciano R, Stehman FB. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2010;117:270–5.

    Article  PubMed  Google Scholar 

  16. Fields AL, Anderson PS, Goldberg GL, Wadler S, Beitler J, Sood B, Runowicz CD. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix. Gynecol Oncol. 1996;61;416–22.

    Article  CAS  PubMed  Google Scholar 

  17. Pras E, Willemse PHB, Boonstra H, et al. Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix. Ann Oncol. 1996;7:511–6.

    Article  CAS  PubMed  Google Scholar 

  18. Rose PG, Ali S, Watkins E, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:2804–10.

    Article  CAS  PubMed  Google Scholar 

  19. Teh J, Yap SP, Tham I, et al. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma, survival outcomes, patterns of failure, and prognostic factors. Int J Gynecol Cancer. 2010;20:428–33.

    Article  PubMed  Google Scholar 

  20. Vale CL, Tierney JF, Davidson SE, Drinkwater KJ, Symonds P. Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists’ audit. Clin Oncol (R Coll Radiol). 2010;22:590–601.

    Article  CAS  Google Scholar 

  21. Pötter R, Georg P, Dimopoulos J, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol. 2011;100:116–23.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kim T, Park B, Kwack H, Kwon JY, Kim JH, Yoon SC. Outcomes and prognostic factors of cervical cancer after concurrent chemoradiation. J Obstet Gynaecol Res. 2012;38:1315–20.

    Article  PubMed  Google Scholar 

  23. Kato S, Ohno T, Thephamongkhol K, et al. Long-term follow-up results of a multi-institutional phase 2 study of concurrent chemoradiation therapy for locally advanced cervical cancer in East and Southeast Asia. Int J Radiat Oncol. 2013;87:100–5.

    Article  Google Scholar 

  24. Zuliani AC, Esteves SC, Teixeira LC, Teixeira JC, de Souza GA, Sarian LO. Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: a randomized controlled trial. J Clin Oncol. 2014;32:542–7.

    Article  PubMed  Google Scholar 

  25. Fanfani F, Fagotti A, Ferrandina G, et al. Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome. Int J Gynecol Cancer. 2009;19:1119–24.

    Article  PubMed  Google Scholar 

  26. Benedetti-Panici P, Maneschi F, Cutillo G, et al. Modified type IV–V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Cancer. 1996;78:2359–65.

    Article  CAS  PubMed  Google Scholar 

  27. Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian Multicenter Randomized Study. J Clin Oncol. 2002;20:179–88.

    Article  CAS  PubMed  Google Scholar 

  28. Mori T, Hosokawa K, Sawada M, et al. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer long-term results. Int J Gynecol Cancer. 2010;20:611–6.

    Article  PubMed  Google Scholar 

  29. NCCN Clinical Practice Guidelines in Oncology 2015, Version I.

  30. Osman M. The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review. Oncol Rev. 2014;8:250.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Cochrane Database Syst. Rev. 2015;4:CD010260.

    Google Scholar 

  32. Kearney GP, Tumeh SS. Urinary tract involvement in gynecologic cancer. Gynecologic Oncology. 2nd ed., New York: McGraw-Hill; 1993:34

    Google Scholar 

  33. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys. 1999;43:763–75.

    Article  CAS  PubMed  Google Scholar 

  34. Höckel M, Horn LC, Tetsch E, Einenkel J. Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy. Gynecol Oncol. 2012;125:168–74.

    Article  PubMed  Google Scholar 

  35. Benedetti-Panici P, Di Donato V, Palaia I, et al. Type B versus type C radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical carcinoma: a propensity-matched analysis. Ann Surg Oncol. 2015;23:1–7.

    Google Scholar 

  36. Ditto A, Martinelli F, Bogani G, et al. Implementation of laparoscopic approach for type B radical hysterectomy: a comparison with open surgical operations. Eur J Surg Oncol. 2015;41:34–9.

    Article  PubMed  Google Scholar 

  37. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;3:CD002225.

    Google Scholar 

  38. Tan LT, Zahra M. Long-term survival and late toxicity after chemoradiotherapy for cervical cancer—the Addenbrooke’s experience. Clin Oncol. 2008;20:358–64.

    Article  CAS  Google Scholar 

Download references

Acknowledgment

We thank Luca Tramontano (Medical Student) for his support in preparation of the manuscript.

Disclosure

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Gynecology Obstetrics Sciences and Urologic Sciences, Umberto I, “Sapienza” University of Rome, Rome, Italy

    Violante Di Donato MD, PhD, Michele Carlo Schiavi MD, Ilary Ruscito MD, Virginia Sibilla Visentin MD, Innocenza Palaia MD, PhD, Claudia Marchetti MD, PhD, Margherita Fischetti MD, Marco Monti MD, Ludovico Muzii MD & Pierluigi Benedetti Panici MD

Authors
  1. Violante Di Donato MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michele Carlo Schiavi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilary Ruscito MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Virginia Sibilla Visentin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Innocenza Palaia MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claudia Marchetti MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Margherita Fischetti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marco Monti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ludovico Muzii MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pierluigi Benedetti Panici MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Violante Di Donato MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Donato, V., Schiavi, M.C., Ruscito, I. et al. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer. Ann Surg Oncol 23 (Suppl 5), 841–849 (2016). https://doi.org/10.1245/s10434-016-5597-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5597-1

Keywords

Search

Navigation